drug discovery
What COVID-19 is teaching us
The virtual EMBL Conference ‘SARS-CoV-2: Towards a New Era in Infection Research’ explored the importance of fundamental research, collaboration, and data science in containing the SARS-CoV-2 pandemic, and discussed opportunities to improve our response to pandemics in the future.…
Welcome: Ellie McDonagh
Open Targets welcomes new Informatics Science Director…
Understanding the influenza virus
The infectious disease commonly known as flu is caused by the influenza virus. It spreads around the world in seasonal outbreaks, causing millions of infections and hundreds of thousands of deaths each year. Stephen Cusack, Head of EMBL Grenoble, has been studying different aspects of the influenza…
EMBL and Tara: Hamburg
EMBL Hamburg and Tara raise awareness of the risks of microplastic pollution and global infection…
Prioritising cancer drug targets using CRISPR
Large CRISPR screen prioritises hundreds of promising genes for personalised cancer treatment…
New Open Targets Director appointed
New director drives drug discovery partnership forward…
Sanofi joins Open Targets
Pharmaceutical company Sanofi strengthens drug targets discovery collaboration Open Targets…
Promega joins EMBL’s Corporate Partnership Programme
EMBL and Promega collaborate to train young scientists…
Celgene joins Open Targets
New partner strengthens drug discovery collaboration…
Futures: Unravelling influenza
ERC grantee Stephen Cusack shares his vision for the next ten years…
